drugset / Trial / NCT04753957

Pharmacokinetics of Progesterone in Pregnancy-2

NCT04753957

Phase 1 Terminated 3 enrolled Thomas Jefferson University
RandomizedParallel-groupOpen-labelOther

Summary

The objective of this study is to evaluate the local pharmacokinetics of progesterone in pregnancy through evaluation of progesterone levels in maternal serum, endometrium, and cordblood in pregnant patients undergoing scheduled cesarean delivery.

Timeline

Start
2022-01-07
Primary completion
2022-02-01
Completion
2022-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg Intrathecal

Indications